SCHEMBL7974255

SCHEMBL7974255

CCc1nc2ncn(Cc3cccc(C)c3)c2c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.47
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KMT2A Q03164 3/20 0.46
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
TSHR P16473 4/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 2/20 0.44
HCAR2 Q8TDS4 1/20 0.42
TP53 P04637 2/20 0.42
MEN1 O00255 2/20 0.42
HSD17B10 Q99714 1/20 0.42
ALOX15 P16050 1/20 0.41
MMP13 P45452 1/20 0.41
MAPT P10636 2/20 0.40
POLB P06746 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988657 0.91 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7984374 0.89 HPGD (0.43) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7988361 0.88 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7992185 0.88 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7984206 0.88 HPGD (0.46) HPGDALDH1A1SMN1; SMN2KMT2ATSHR
SCHEMBL7984753 0.88 SMN1; SMN2 (0.51) HPGDALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL7975251 0.87 SMN1; SMN2 (0.60) HPGDALDH1A1SMN1; SMN2KMT2ATP53
SCHEMBL7987432 0.86 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7984496 0.86 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL7984510 0.86 GAA (0.53) HPGDALDH1A1SMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed